ERNA
Price
$1.56
Change
-$0.17 (-9.83%)
Updated
Aug 1 closing price
Capitalization
11.34M
TENX
Price
$6.22
Change
-$0.02 (-0.32%)
Updated
Aug 1 closing price
Capitalization
25.8M
Interact to see
Advertisement

ERNA vs TENX

Header iconERNA vs TENX Comparison
Open Charts ERNA vs TENXBanner chart's image
Ernexa Therapeutics
Price$1.56
Change-$0.17 (-9.83%)
Volume$54.69K
Capitalization11.34M
Tenax Therapeutics
Price$6.22
Change-$0.02 (-0.32%)
Volume$10.29K
Capitalization25.8M
ERNA vs TENX Comparison Chart in %
Loading...
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.34B. The market cap for tickers in the group ranges from 58 to 213.98B. NONOF holds the highest valuation in this group at 213.98B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 17%, and the average quarterly price growth was 37%. MRSN experienced the highest price growth at 2,039%, while PBM experienced the biggest fall at -79%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was 38% and the average quarterly volume growth was 123%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 57
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -11 (-100 ... +100)

Market Cap

The average market capitalization across the group is 18.57M. The market cap for tickers in the group ranges from 11.34M to 25.8M. TENX holds the highest valuation in this group at 25.8M. The lowest valued company is ERNA at 11.34M.

High and low price notable news

The average weekly price growth across all stocks in the group was -9%. For the same group, the average monthly price growth was -6%, and the average quarterly price growth was -34%. TENX experienced the highest price growth at 3%, while ERNA experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the group was 513%. For the same stocks of the group, the average monthly volume growth was 941% and the average quarterly volume growth was 75%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 71
Price Growth Rating: 54
SMR Rating: 98
Profit Risk Rating: 100
Seasonality Score: -28 (-100 ... +100)
VS
ERNA vs. TENX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERNA is a Hold and TENX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (ERNA: $1.56 vs. TENX: $6.22)
Brand notoriety: ERNA and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERNA: 58% vs. TENX: 33%
Market capitalization -- ERNA: $11.34M vs. TENX: $25.8M
ERNA [@Biotechnology] is valued at $11.34M. TENX’s [@Biotechnology] market capitalization is $25.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERNA’s FA Score shows that 0 FA rating(s) are green whileTENX’s FA Score has 1 green FA rating(s).

  • ERNA’s FA Score: 0 green, 5 red.
  • TENX’s FA Score: 1 green, 4 red.
According to our system of comparison, TENX is a better buy in the long-term than ERNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERNA’s TA Score shows that 5 TA indicator(s) are bullish while TENX’s TA Score has 5 bullish TA indicator(s).

  • ERNA’s TA Score: 5 bullish, 3 bearish.
  • TENX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ERNA and TENX are a good buy in the short-term.

Price Growth

ERNA (@Biotechnology) experienced а -20.00% price change this week, while TENX (@Biotechnology) price change was +2.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

ERNA is expected to report earnings on May 07, 2025.

TENX is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TENX($25.8M) has a higher market cap than ERNA($11.3M). TENX YTD gains are higher at: 0.485 vs. ERNA (-64.626). TENX has higher annual earnings (EBITDA): -24.2M vs. ERNA (-33.53M). TENX has more cash in the bank: 111M vs. ERNA (1.92M). TENX has less debt than ERNA: TENX (279K) vs ERNA (2.88M). ERNA has higher revenues than TENX: ERNA (535K) vs TENX (0).
ERNATENXERNA / TENX
Capitalization11.3M25.8M44%
EBITDA-33.53M-24.2M139%
Gain YTD-64.6260.485-13,335%
P/E RatioN/A3.68-
Revenue535K0-
Total Cash1.92M111M2%
Total Debt2.88M279K1,033%
FUNDAMENTALS RATINGS
ERNA vs TENX: Fundamental Ratings
ERNA
TENX
OUTLOOK RATING
1..100
521
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6643
P/E GROWTH RATING
1..100
10043
SEASONALITY SCORE
1..100
n/a29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for ERNA (58). This means that TENX’s stock grew somewhat faster than ERNA’s over the last 12 months.

TENX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ERNA (100). This means that TENX’s stock grew similarly to ERNA’s over the last 12 months.

TENX's SMR Rating (96) in the Medical Specialties industry is in the same range as ERNA (100). This means that TENX’s stock grew similarly to ERNA’s over the last 12 months.

TENX's Price Growth Rating (43) in the Medical Specialties industry is in the same range as ERNA (66). This means that TENX’s stock grew similarly to ERNA’s over the last 12 months.

TENX's P/E Growth Rating (43) in the Medical Specialties industry is somewhat better than the same rating for ERNA (100). This means that TENX’s stock grew somewhat faster than ERNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ERNATENX
RSI
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend about 1 month ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATPC1.350.06
+4.67%
Agape ATP Corporation
SU39.04-0.42
-1.06%
Suncor Energy
RNA35.92-0.79
-2.15%
Avidity Biosciences
PERI10.57-0.25
-2.31%
Perion Network Ltd
PLBC40.01-0.95
-2.32%
Plumas Bancorp

ERNA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ERNA has been loosely correlated with CGEN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ERNA jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERNA
1D Price
Change %
ERNA100%
-9.83%
CGEN - ERNA
39%
Loosely correlated
+2.07%
MDGL - ERNA
36%
Loosely correlated
-0.11%
IBIO - ERNA
32%
Poorly correlated
-3.09%
SMMT - ERNA
31%
Poorly correlated
+2.65%
CYTK - ERNA
29%
Poorly correlated
-2.52%
More

TENX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been loosely correlated with AVXL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TENX jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
-0.32%
AVXL - TENX
47%
Loosely correlated
-0.88%
SBHMY - TENX
42%
Loosely correlated
N/A
CORT - TENX
41%
Loosely correlated
+2.72%
ADVM - TENX
36%
Loosely correlated
-2.93%
COYA - TENX
30%
Poorly correlated
+2.35%
More